3D-printed Microfluidic Device Research Articles

Online Aerosol pH Detection Using 3D-Printed Microfluidic Devices with a Novel Magnetic SERS Sensor.

Accurate measurement of aerosol pH is crucial for understanding atmospheric processes and mitigating haze pollution. However, online detection of aerosol pH is challenging due to the complex composition of single-particle matter and trace components. This study develops a sensitive and selective sensor for the online detection of aerosol pH using surface-enhanced Raman spectroscopy (SERS). A novel Fe3O4@SiO2@Au-p-aminothiophenol (FA-pATP) sensor was fabricated using a layer-by-layer self-assembly method, achieving enhanced uniformity and increased density of SERS-active hotspots. Magnetic aggregation was employed to further amplify the Raman signal. This sensor was integrated into a 3D-printed microfluidic device to facilitate online monitoring of aerosol pH. The FA-pATP sensor exhibited a significant increase in peak intensity ratio with rising pH, demonstrating high sensitivity and responsiveness due to structural changes in the -NH2 groups of pATP under different pH conditions. The sensor demonstrated a linear pH response ranging from 5 to 11. The 3D-printed microfluidic device, coupled with the FA-pATP sensor, demonstrated notable performance in various environmental media, indicating strong anti-interference capabilities. The proposed sensor shows great promise for real-time online monitoring of aerosol pH, with broad applications in environmental monitoring.

Amphotericin B Ocular Films for Fungal Keratitis and a Novel 3D-Printed Microfluidic Ocular Lens Infection Model.

Fungal keratitis (FK), a severe eye infection that leads to vision impairment and blindness, poses a high risk to contact lens users, and Candida albicans remains the most common underpinning fungal pathogen in temperate climates. Patients are initially treated empirically (econazole 1% drops hourly for 24-48 h), and if there is no response, amphotericin B (AmB) 0.15% eye drops (extemporaneously manufactured to be stable for a week) are the gold-standard treatment. Here, we aim to develop a sustained-release AmB ocular film to treat FK with an enhanced corneal retention time. As there is a paucity of reliable in vitro models to evaluate ocular drug release and antifungal efficacy under flow, we developed a 3D-printed microfluidic device based on four chambers stacked in parallel, in which lenses previously inoculated with a C. albicans suspension were placed. Under the flow of a physiological fluid over 24 h, the release from the AmB-loaded film that was placed dry onto the surface of the wetted contact lenses was quantified, and their antifungal activity was assessed. AmB sodium deoxycholate micelle (dimeric form) was mixed with sodium alginate and hyaluronic acid (3:1 w/w) and cast into films (0.48 or 2.4%), which showed sustained release over 24 h and resulted in a 1.23-fold reduction and a 5.7-fold reduction in CFU/mL of C. albicans, respectively. This study demonstrates that the sustained delivery of dimeric AmB can be used for the treatment of FK and provides a facile in vitro microfluidic model for the development and testing of ophthalmic antimicrobial therapies.

3D-printed microfluidic and millifluidic devices for cell culture and mechanotransduction studies: A review

The practice of conventional cell culture techniques affects the quality of biological research in mechanobiology by not replicating the cell’s microenvironment adequately. Microfluidic devices resembling 3D in vivo cell culture offer viable alternatives for mechanobiology studies and other applications including cell screening, cell separation, and point-of-care diagnostics. This review highlights recent advances in additive manufacturing (AM) to fabricate microfluidic and millifluidic devices through fast design iterations and cost reduction compared with conventional device manufacturing. Key advances in AM technologies such as fused deposition modeling (FDM), stereolithography apparatus (SLA), and digital light processing (DLP) have allowed the direct manufacture of complex microfluidic devices with master molds and sacrificial structures using multiple material components. Currently, available 3D printed devices for the precise fabrication of milli- and microfluidic devices, essential to mimicking the cellular microenvironment, while economically reducing production costs by eliminating expensive clean-room environments and reducing material waste are highlighted.

Complement C5a Implication in Axonal Growth After Injury.

Complement C5a protein has been shown to play a major role in tissue regeneration through interaction with its receptor (C5aR) on target cells. Expression of this receptor has been reported in the nervous system which, upon injury, has no treatment to restore the lost functions. This work aimed at investigating the Complement C5a effect on axonal growth after axotomy in vitro. Primary hippocampal neurons were isolated from embryonic Wistar rats. Cell expression of C5aR mRNA was verified by RT-PCR while its membrane expression, localization, and phosphorylation were investigated by immunofluorescence. Then, the effects of C5a on injured axonal growth were investigated using a 3D-printed microfluidic device. Immunofluorescence demonstrated that the primary cultures contained only mature neurons (93%) and astrocytes (7%), but no oligodendrocytes or immature neurons. Immunofluorescence revealed a co-localization of NF-L and C5aR only in the mature neurons where C5a induced the phosphorylation of its receptor. C5a application on injured axons in the microfluidic devices significantly increased both the axonal growth speed and length. Our findings highlight a new role of C5a in regeneration demonstrating an enhancement of axonal growth after axotomy. This may provide a future therapeutic tool in the treatment of central nervous system injury.

Quantification of elastic modulus variations during zebrafish embryo development using a 3D-printed microfluidic platform

Reliable indicators to assess embryo quality are critical for the in vitro fertilization. Increasing evidence suggests that elasticity is emerging as a potential marker to evaluate the early development of embryos. This paper introduces a 3D-printed microfluidic device to measure the elastic modulus of zebrafish embryos deformed in a circular constriction channel. Firstly, numerical simulation was performed to analyze the impact of inlet pressure, embryo size and constriction channel diameter on the maximum protrusion length of the embryo. Subsequently, the zebrafish embryos were deformed using the device to record the protrusion length which was automatically measured using U-net, before the power-law rheological model was employed to calculate the elastic modulus. Experiments showed the power-law exponent and embryo elasticity were stable as the inlet pressure was not less than 250 mbar. Embryo culturing after squeezes revealed that embryos could maintain normal development even after multiple squeezes at 150 mbar while higher pressure may be fatal. Afterward, the deformation of the yolk was found to increase elasticity by 60.4 % compared to cases where only the chorion envelope was deformed. Finally, the elasticity variation of zebrafish embryos was measured for 17 hours. It revealed that the elasticity initially increased from hour 1 to hour 7–10 and then returned to approximately the original value during culture from the cleavage to the segmentation stages. The system with the ability of precise and long-term assessment of embryo elasticity may find valuable application potentials in the mechanical evaluation and sorting of embryos.

Microfluidic Gastrointestinal Cell Culture Technologies-Improvements in the Past Decade.

Gastrointestinal cell culture technology has evolved in the past decade with the integration of microfluidic technologies, bringing advantages with greater selectivity and cost effectiveness. Herein, these technologies are sorted into three categories, namely the cell-culture insert devices, conventional microfluidic devices, and 3D-printed microfluidic devices. Each category is discussed in brief with improvements also discussed here. Introduction of different companies and applications derived from each are also provided to encourage uptake. Subsequently, future perspectives of integrating microfluidics with trending topics like stool-derived in vitro communities and gut-immune-tumor axis investigations are discussed. Insights on modular microfluidics and its implications on gastrointestinal cell cultures are also discussed here. Future perspectives on point-of-care (POC) applications in relations to gastrointestinal microfluidic devices are also discussed here. In conclusion, this review presents an introduction of each microfluidic platform with an insight into the greater contribution of microfluidics in gastrointestinal cell cultures.

(Invited) Multiplexed CRISPR-Based ECL Assay for Alzheimer’s Biomarkers

Currently, more than 6 million Americans live with Alzheimer’s disease (AD), and it is projected to be 13 million by 2050. AD has no permanent cure yet, and early detection is important to slow down the progress of the disease. Diagnosis is complicated by AD’s similarity to other geriatric diseases. Beta-amyloid peptide (Aβ42), tau proteins and neurofilament light (NFL) measured in the cerebrospinal fluid (CSF) is a reasonably effective method for diagnostics, but very painful for the patients. MicroRNA’s (miRNAs) expressed in the brain are promising biomarkers and our goal of this study is to develop a sensitive and selective point-of-care (POC) test to detect AD specific miRNA (miRNA 30e, 34c and 200c) based on the CRISPR-Cas system. The Cas 13a protein has the regular sequence specific RNase activity followed by a collateral RNase activity. We used this feature of Cas 13a to generate an electrochemiluminescence (ECL) signal by binding specific miRNA biomarkers, and then collaterally cleaving poly-ribose guanine (poly-rG). This cleaved strands of poly-rG and rG itself are coreactants for ECL, and react with ECL polymer Ruthenium Polyvinyl Pyridine (RuPVP) to generate ECL. RuPVP is deposited into pyrolytic graphite (PG) micro wells. Using a 3D-printed microfluidic device equipped with the Pt reference and Ag/AgCl counter electrodes, patient serum mixed with poly-rG is introduced to the RuPVP coated electrode at 1.3 V to provide ECL light measured by a CCD camera. The assay was multiplexed to detect 3 AD specific miRNAs, and obtain a separate calibration for each miRNA biomarker with linear ranges from 70 pg/ mL to 7 µg/mL, from 7.4 pg/ mL to 74 µg/ mL and from 7.4 fg/ mL to 74 µg/ mL for 30e, 34c and 200c respectively. Preliminary LODs were 42 pg/ mL, 0.074 fg/ mL and 0.15 fg/ mL for miRNA 30e, 34c and 200c respectively. Results confirm the sensitivity of the assay. Further, spike recovery, cross reactivity studies and patient sample assays will be reported.

Towards personalized microfluidics: 3D printing of high-performance micropumps by control and optimization of fabrication-induced surface roughness

Additive fabrication technologies are very attractive for use in the realization of customized medical diagnostic and point-of-care devices in the rapidly growing field of personalized healthcare. However, non-idealities in additive manufacturing processes, such as the enhanced roughness that is inherent to many such processes, limit the use of these fabrication technologies in real products. In this work, the effect of additive fabrication-induced surface roughness on fluid flow within material extrusion (MEX) 3D-printed microfluidic devices is modeled and experimentally validated. An optimization process to eliminate such effects in functional 3D-printed devices is developed. By the resulting careful model-driven optimization, high-performance printed glass and Acrylonitrile butadiene styrene (ABS) valveless micropumps are demonstrated in this work for the first time. Water flow rates of 210 µl min−1 and 140 µl min−1 for the ABS and the glass micropumps respectively, and a maximum working backpressure of 978 Pa at an actuation signal of 68 Hz and 120 Vpp are achieved, attesting to the viability of additive fabrication to realize functional microfluidic devices.

A 3D-printed tumor-on-chip: user-friendly platform for the culture of breast cancer spheroids and the evaluation of anti-cancer drugs

Tumor-on-chips (ToCs) are useful platforms for studying the physiology of tumors and evaluating the efficacy and toxicity of anti-cancer drugs. However, the design and fabrication of a ToC system is not a trivial venture. We introduce a user-friendly, flexible, 3D-printed microfluidic device that can be used to culture cancer cells or cancer-derived spheroids embedded in hydrogels under well-controlled environments. The system consists of two lateral flow compartments (left and right sides), each with two inlets and two outlets to deliver cell culture media as continuous liquid streams. The central compartment was designed to host a hydrogel in which cells and microtissues can be confined and cultured. We performed tracer experiments with colored inks and 40 kDa fluorescein isothiocyanate dextran to characterize the transport/mixing performances of the system. We also cultured homotypic (MCF7) and heterotypic (MCF7-BJ) spheroids embedded in gelatin methacryloyl hydrogels to illustrate the use of this microfluidic device in sustaining long-term micro-tissue culture experiments. We further demonstrated the use of this platform in anticancer drug testing by continuous perfusion of doxorubicin, a commonly used anti-cancer drug for breast cancer. In these experiments, we evaluated drug transport, viability, glucose consumption, cell death (apoptosis), and cytotoxicity. In summary, we introduce a robust and friendly ToC system capable of recapitulating relevant aspects of the tumor microenvironment for the study of cancer physiology, anti-cancer drug transport, efficacy, and safety. We anticipate that this flexible 3D-printed microfluidic device may facilitate cancer research and the development and screening of strategies for personalized medicine.

Compound Droplet Generation by a Hybrid Microfluidic Device.

Microfluidic technology based on a compound droplet plays an increasingly significant role in different disciplines, such as genetic detection, drug transportation, and cell culture. Low-cost, stable, and rapid methods to produce compound droplets are more and more in demand. In this paper, a hybrid 3D-printed microfluidic device was designed to realize efficient fabrication of multicore compound droplets, where a first oil phase (O1) is cut by a water phase (W) to form pure O1 droplets, and then the W phase containing O1 droplets is cut by a second oil phase (O2) to generate multicore compound droplets. A series of experiments were conducted to determine the influence of the flow rate and viscosity on the formation dynamics of compound droplets. It is found that the number of inner cores is mainly affected by the W and O2 phases, and a W phase with higher viscosity and a higher flow rate is more likely to produce compound droplets with more inner cores. This work provides new insights into the formation dynamics of compound droplets and can contribute to the optimization of emulsion production.

Advancing Tissue Culture with Light-Driven 3D-Printed Microfluidic Devices.

Three-dimensional (3D) printing presents a compelling alternative for fabricating microfluidic devices, circumventing certain limitations associated with traditional soft lithography methods. Microfluidics play a crucial role in the biomedical sciences, particularly in the creation of tissue spheroids and pharmaceutical research. Among the various 3D printing techniques, light-driven methods such as stereolithography (SLA), digital light processing (DLP), and photopolymer inkjet printing have gained prominence in microfluidics due to their rapid prototyping capabilities, high-resolution printing, and low processing temperatures. This review offers a comprehensive overview of light-driven 3D printing techniques used in the fabrication of advanced microfluidic devices. It explores biomedical applications for 3D-printed microfluidics and provides insights into their potential impact and functionality within the biomedical field. We further summarize three light-driven 3D printing strategies for producing biomedical microfluidic systems: direct construction of microfluidic devices for cell culture, PDMS-based microfluidic devices for tissue engineering, and a modular SLA-printed microfluidic chip to co-culture and monitor cells.

Manipulation of encapsulated artificial phospholipid membranes using sub-micellar lysolipid concentrations

Droplet Interface Bilayers (DIBs) constitute a commonly used model of artificial membranes for synthetic biology research applications. However, their practical use is often limited by their requirement to be surrounded by oil. Here we demonstrate in-situ bilayer manipulation of submillimeter, hydrogel-encapsulated droplet interface bilayers (eDIBs). Monolithic, Cyclic Olefin Copolymer/Nylon 3D-printed microfluidic devices facilitated the eDIB formation through high-order emulsification. By exposing the eDIB capsules to varying lysophosphatidylcholine (LPC) concentrations, we investigated the interaction of lysolipids with three-dimensional DIB networks. Micellar LPC concentrations triggered the bursting of encapsulated droplet networks, while at lower concentrations the droplet network endured structural changes, precisely affecting the membrane dimensions. This chemically-mediated manipulation of enclosed, 3D-orchestrated membrane mimics, facilitates the exploration of readily accessible compartmentalized artificial cellular machinery. Collectively, the droplet-based construct can pose as a chemically responsive soft material for studying membrane mechanics, and drug delivery, by controlling the cargo release from artificial cell chassis.

Open-source interactive design platform for 3D-printed microfluidic devices

Microfluidics and 3D printing offer exciting opportunities for the development of new technologies and applications in the fields of biology, chemistry, and medicine. However, the design of 3D-printed microfluidic devices remains a challenging and complex task, requiring specialized knowledge and expertise in fluid mechanics, 3D modeling, and 3D printing technology. Currently, there are very few tools helping engineers to do the labor-intensive process of designing microfluidic devices, let alone any tools that can help them design microfluidic devices for 3D printing. In this work, we introduce Flui3d, an interactive software platform for designing microfluidic devices for 3D printing. Flui3d offers a standard parameterized component library, support for multi-layer design, and the ability to design and configure microfluidic devices without the need for specialized knowledge. Flui3d incorporates a distinctive Design-for-Manufacturing (DFM) function, facilitating seamless fabrication of the designed microfluidic devices using commercial consumer-grade printers. We discuss the key features and benefits of Flui3d and demonstrate them by designing examples of microfluidic devices. We also discuss the design complexity and the potential applications of Flui3d.

Development of a 3D Microfluidic Analytical Device for the Detection of Pathogenic Bacteria in Commercial Food Samples with Loop-Mediated Isothermal Amplification

Traditional methods of detecting foodborne pathogens take several days to produce the required results. Furthermore, various molecular techniques (e.g., PCR) that also produce reliable results in the detection of pathogenic bacteria have been introduced, but the cost–time ratio required does not allow them to be considered a substantial solution to this specific problem. Three-dimensional (3D) printing technology provides the ability to design and manufacture microfluidic analytical devices using conventional 3D printers, which, in combination with colorimetric loop-mediated isothermal amplification (LAMP), may further simplify the process. The overall reduction in time and cost may provide the opportunity to upscale this diagnostic modality. Moreover, unlike most microfluidic analytical devices, this technique is simpler and more user-friendly, as it does not require any expertise or additional equipment apart from a conventional oven. A 3D-printed microfluidic analytical device in combination with LAMP was developed and tested for the simultaneous detection of foodborne pathogens in food samples. A total of 150 commercial food specimens (50 milk, 50 chicken, 50 lettuce samples) were analyzed for possible contamination with Salmonella typhimurium, Listeria monocytogenes and Escherichia coli. The 3D-printed microfluidic device was 100% precise for both negative (80 samples) and positive samples (7 samples were positive for S. typhimurium, 28 for L. monocytogenes, and 35 for E. coli) for all pathogens. Overall, the amount of data analyzed led to a high level of confidence in the precision of this device. As such, this new 3D device in combination with LAMP provides a precise detection method for food pathogens with a low detection limit.

Universal Biomaterial-on-Chip: a versatile platform for evaluating cellular responses on diverse biomaterial substrates

Microfluidics has emerged as a promising approach for assessing cellular behavior in vitro, providing more physiologically relevant cell culture environments with dynamic flow and shear stresses. This study introduces the Universal Biomaterial-on-Chip (UBoC) device, which enables the evaluation of cell response on diverse biomaterial substrates in a 3D-printed microfluidic device. The UBoC platform offers mechanical stimulation of the cells and monitoring of their response on diverse biomaterials, enabling qualitative and quantitative in vitro analysis both on- and off-chip. Cell adhesion and proliferation were assessed to evaluate the biocompatibility of materials with different physical properties, while mechanical stimulation was performed to investigate shear-dependent calcium signaling in pre-osteoblasts. Moreover, the applicability of the UBoC platform in creating more complex in vitro models by culturing multiple cell types was demonstrated, establishing a dynamic multicellular environment to investigate cellular interfaces and their significance in biological processes. Overall, the UBoC presents an adaptable tool for in vitro evaluation of cellular behavior, offering opportunities for studying various biomaterials and cell interactions in microfluidic environments.Graphical

Additive-manufactured paper-PMMA hybrid microfluidic chip for simultaneous monitoring of creatinine and pH in artificial urine.

Nowadays, kidney dysfunction is a common health issue due to the modernized lifestyle. Even though medications are commercially available to treat kidney diseases, early diagnosis is crucial and challenging. Clinically, measuring urine creatinine and pH has gained significant interest as a way to diagnose kidney diseases early. In the present work, we attempted to develop a low-cost, robust, accurate and naked-eye colorimetric method to determine both creatinine levels and pH variations in artificial urine samples using a simple 3D-printed hybrid microfluidic device. Creatinine was detected by the incorporation of the traditional Jaffe test onto the hybrid paper-PMMA microfluidic device and pH (4-8) was measured by a simple anthocyanin test. Notably, the tests were established without employing any sophisticated or costly instrument clusters. The developed 3D-printed microfluidic probe showed a limit of detection (LOD) of 0.04 mM for creatinine over a concentration range of 1-10 mM, with a regression coefficient (R2) of 0.995 in laboratory conditions. Interestingly, the experimental data obtained with artificial urine exhibited a wide linear range from 0.1 mM to 5 mM under different pH values ranging from 4 to 8 in the presence of matrices commonly found in urine samples other than proteins, indicating the potential use of this method in pre-clinical analysis. Since the wide linear range of urine creatinine in artificial urine samples falls well below the clinically relevant concentrations in humans (0.07-0.27 mM), the developed lab-on-chip device is further suitable for clinical evaluation with proper ethical clearance. This 3D-printed hybrid microfluidic colorimetry-based creatinine detection and pH indicator platform can be beneficial in the healthcare sector due to the on-site testing capability, cost-effectiveness, ease of use, robustness, and instrument-free approach.

3D-printed microfluidic device for high-throughput production of lipid nanoparticles incorporating SARS-CoV-2 spike protein mRNA.

Lipid nanoparticles (LNPs) are drug carriers for protecting nucleic acids for cellular delivery. The first mRNA vaccines authorized by the United States Food and Drug Administration are the mRNA-1273 (Moderna) and BNT162b (BioNTech/Pfizer) vaccines against coronavirus disease 2019 (COVID-19). We designed a 3D printed Omnidirectional Sheath-flow Enabled Microfluidics (OSEM) device for producing mRNA-loaded LNPs that closely resemble the Moderna vaccine: we used the same lipid formulations to encapsulate mRNA encoding SARS-CoV-2 spike protein. The OSEM device is made of durable methacrylate-based materials that can support flow rates in the mL min-1 range and was fabricated by stereolithography (SLA), incorporating readily adaptable interfaces using commercial fluidic connectors. Two key features of the OSEM device are: 1) a 4-way hydrodynamic flow focusing region and 2) a staggered herringbone mixer (SHM). Superior to conventional planar fluid junctions, the 4-way sheath flow channel generates an evenly focused, circular center flow that facilitates the formation of LNPs with low polydispersity. Downstream, fluid mixing in the SHM is intensified by incorporating a zig-zag fluidic pathway to deliver high mRNA encapsulation efficiency. We characterized the mRNA-loaded LNPs produced in the OSEM device and showed that the enhanced 3D microfluidic structures enable a 5-fold higher throughput production rate (60 mL min-1) of LNPs compared to commercial multi-thousand-dollar micromixers. The device produced LNPs of diameter less than 90 nm, with low polydispersity (2-8%) and high mRNA encapsulation efficiency (>90%). The 3D-printed device provides a cost-effective and easily prepared solution for high-throughput LNP production.

Synergistic effects of fibrin-enriched adipose decellularized extracellular matrix (AdECM) and microfluidic model on vascularization.

Vasculature is essential for maintaining the cellular function and balance of organs and tumors. As a key component of the tumor microenvironment (TME), it significantly influences tumor characteristics. Angiogenesis, heavily influenced by the extracellular matrix (ECM), which acts as a structural scaffold and growth factor reservoir, is regulated by various factors. Notably, adipose tissues and adipose-derived stromal cells contribute angiogenic and anti-apoptotic factors that promote angiogenesis. Sustained vasculature is essential for tissue engineering and ex vivo disease modeling. Lack of shear stress from fluid flow leads to vascular instability and regression. Microfluidic models replicate three-dimensional (3D) cultures from original tissues, encapsulate microenvironmental factors, and maintain consistent fluid flow. In our study, we established decellularized adipose ECM (AdECM) derived from bovine sources and engineered a 3D-printed microfluidic device. We observed significant increases in both the length and diameter of vascular networks after coculturing HUVECs and HDFs in a fibrin gel containing 0.5% AdECM. Additionally, gene expression related to ECM remodeling and angiogenesis was significantly enhanced in vasculature cultivated in fibrin gel containing 0.5% AdECM compared to that in fibrin gel alone. The enhanced vasculogenesis was further amplified and sustained by the 3D microfluidic device placed on a rocker during extended cultivation, primarily through the activation of the PI3K and JAK-mediated pathways. Our ex vivo model with vascularized colon tumoroids revealed that integrating AdECM within a microfluidic device correlates with increased tumoroid growth. Therefore, our study underscores the synergistic impact of AdECM and microfluidic device in promoting and sustaining vasculature. This synergy may have significant implications for tissue regeneration and ex vivo disease modeling, facilitating drug testing and efficacy evaluation.

Surface-Wetting Characteristics of DLP-Based 3D Printing Outcomes under Various Printing Conditions for Microfluidic Device Fabrication.

In recent times, the utilization of three-dimensional (3D) printing technology, particularly a variant using digital light processing (DLP), has gained increasing fascination in the realm of microfluidic research because it has proven advantageous and expedient for constructing microscale 3D structures. The surface wetting characteristics (e.g., contact angle and contact angle hysteresis) of 3D-printed microstructures are crucial factors influencing the operational effectiveness of 3D-printed microfluidic devices. Therefore, this study systematically examines the surface wetting characteristics of DLP-based 3D printing objects, focusing on various printing conditions such as lamination (or layer) thickness and direction. We preferentially examine the impact of lamination thickness on the surface roughness of 3D-printed structures through a quantitative assessment using a confocal laser scanning microscope. The influence of lamination thicknesses and lamination direction on the contact angle and contact angle hysteresis of both aqueous and oil droplets on the surfaces of 3D-printed outputs is then quantified. Finally, the performance of a DLP 3D-printed microfluidic device under various printing conditions is assessed. Current research indicates a connection between printing parameters, surface roughness, wetting properties, and capillary movement in 3D-printed microchannels. This correlation will greatly aid in the progress of microfluidic devices produced using DLP-based 3D printing technology.

(Invited) All-3D-Printed Devices for Electrochemical Sensing

Three-dimensional (3D) printing has gained significant attention in research laboratories, since it provides the end user with the freedom and ability to produce in-house and on-demand specific electrochemical platforms in a fast and affordable way. The most applied 3D-printing technology in the manufacturing of electrochemical sensors is fused deposition modeling (FDM) which is based on the e-printing of the device by thermoplastic filaments. In particular, the use of FDM for the printing of sensors offers noteworthy advantages compared to conventional fabrication technologies, such as desktop-sized equipment, very low capital, operational, and materials costs, easy fabrication process, design transferability (as the respective file format can be transferred through e-mail and printed on every dual extruder 3D printer), and ecofriendliness (since no waste is produced) [1,2].This presentation will discuss our recent developments of all-3D-printed integrated mini devices and their applications to electrochemical sensing [3-6]. The devices are printed from specific filaments (conductive and non-conductive) at different sizes and shapes, by a dual extruder 3D-printer, in order to fit to the demands of numerous applications. More specifically, all-3D-printed electrochemical microtitration wells for the in-situ and micro-volume quantum dot-based bioassays, as well as a 3D-printed wearable glucose monitoring device in the form of an electrochemical ring will be described. Besides, a 3D-printed wearable device in the form of an electrochemical finger for date rape drugs screening and a 3D-printed microfluidic device modified with metallic film for the trace determination of heavy metals will be presented.Acknowledgements:I thank the Special Account for Research Grants of National and Kapodistrian University of Athens for the financial support.References A. Abdalla and B. A. Patel, Curr. Opin. Electrochem., 20 (2020) 78–81.E. J. Carrasco-Correa, E. F. Simó-Alfonso, J. M. Herrero-Martínez, M. Miró, TrAC - Trends Anal. Chem., 136 (2021) 116177.A Baltima, H. Panagopoulou, A. Economou, C. Kokkinos, Anal. Chim. Acta 1159 (2021) 338426.V. Katseli, M. Angelopoulou, C. Kokkinos, Adv. Funct. Mater., 31 (2021) 2102459.V. Katseli, A. Economou, C. Kokkinos, Anal. Chem. 93 (2021) 3331−3336.G. Poulladofonou, C. Freris, A. Economou, C. Kokkinos, Anal. Chem. 94 (2022) 4087−4094.